Menu Close

‘Groundbreaking’ Gene-Editing Therapy Receives Ethical Thumbs Up

EWTN News Nightly
In an interview with ‘EWTN News Nightly’ anchor Tracy Sabol, National Catholics Bioethics Center President Dr. Joseph Meaney discusses the first-ever therapy approved by the FDA using CRISPR, a genome editing technology.

Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.